Background: Three human polyomaviruses have been classified as probable (MCV) or possible
Introduction
Polyomaviruses cause common, asymptomatic infections, and antibodies persist throughout life (1) as possible carcinogens (1) . In the only three epidemiologic studies (2) (3) (4) to examine associations of BKV and JCV antibodies with risk of non-Hodgkin lymphoma (NHL) or NHL subtypes, no associations were found for BKV, but for JCV results were inconsistent. The only study to examine MCV and risk of NHL showed positive associations with some NHL subtypes (4) . Because of the limited number of studies to date, we examined associations of plasma antibody levels of JCV, BKV and MCV-as well as several other polyomaviruses (WU polyomavirus (WUV); KI polyomavirus (KIV); human polyomavirus 6 (HPy6); human polyomavirus 7 (HPy7); Trichodysplasia spinulosa-associated polyomavirus (TSV)) -
with risk of NHL in the American Cancer Society (ACS) Cancer Prevention Study-II (CPS-II) Nutrition
Cohort, a large prospective study of U.S. men and women.
Materials and Methods
Participants in this nested case-control study were selected from the subgroup of CPS-II participants who provided a blood sample between 1998 and 2001 (n=39,371) (5). Lymphomas (n=279) were reported on biennial questionnaires and verified through medical records (n=209) or registry linkage (n=70). NHL subtypes were categorized using INTERLYMPH guidelines (6) . For each case, two controls were incidence density matched on sex, race, birth and blood draw dates (+/-6 months). quantifies the bead-bound fluorescence-stained human antibodies for each plasma sample and antigen as median fluorescence intensity (MFI) (7, 8) . Coefficients of variation for quality control samples were between 1.8% and 5.1%; intraclass correlation coefficients were between 93.6% and 99.7%. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using conditional logistic regression for all NHL, and unconditional polytomous logistic regression (controlling for the matching factors) for the NHL subtypes. Median MFI values for cases and controls were compared using the Wilcoxon Rank Sum test.
Seropositive MFI values were ≥250. Associations with seropositivity and antibody levels were analyzed for each virus. Cutpoints for the latter analysis were based on quartiles of MFI among seropositive control participants. Cubic splines were used to assess potential nonlinear associations.
Results
The final study population was 836 participants (279 cases, 557 controls), aged 56 -83 years (median: 70) at blood draw. Median age at NHL diagnosis was 74 years. Controls were slightly more likely than cases to be non-obese (85.3% v. 83.2%), non-smokers (49.9% v. 47.3%), non-drinkers (36.6% v. 30.8%), and to live in the U.S. Midwest (34.6% v. 29%), but none of these differences were statistically significant.
Seroprevalence of the polyomaviruses among cases and controls respectively were as follows, BKV: 87.5%, 89.4%; JCV 61.7%, 60.3%; MCV 70.6%, 68.8%; HPyV6: 77.1%, 75.0%; HPyV7 60.6%, 61.8%; WUV 97.9%, 99.1%; KIV 94.3%, 95.7%; TSV: 83.9%, 80.3%. There were no case-control differences in median MFI values for any of the polyomaviruses (data not shown). An inverse trend was suggested for TSV antibodies and risk of NHL but the hazard ratios were not statistically significant (Table 1) . No other associations were observed for seropositivity or elevated antibody levels of the polyomaviruses and risk of NHL. For the NHL subtypes, the only observed association was between TSV and CLL/SLL (Table 2) .
Restricted cubic splines did not suggest any nonlinearity in the associations of polyomavirus antibody levels and risk of NHL or NHL subtypes (data not shown).
Discussion
Results from this prospective study do not support associations between BKV, JCV, WUV, KIV, HPyV6, 
HPyv7, MCV and NHL risk. Though an association was observed for TSV and CLL/SLL, and an inverse trend was suggested for TSV and NHL overall (p=0.03), spline analyses did not detect any linear or nonlinear associations, and chance seems a likely explanation. Three seroepidemiologic studies of human polyomaviruses and NHL risk have been published to date. For BKV, findings from all three were null for all NHL (2, 3) and DLBCL (4). For JCV, positive (2) and inverse (3) associations have been reported with all NHL as well as a null (4) association with DLBCL. Unlike our findings, one study (4) found a positive association for MCV and DLBCL. The prospective design of our study minimized the potential for reverse causation by the lymphoma or its treatment. However, the NHL subtype results must be interpreted with caution given sample size limitations. In summary, this study does not support any associations between human polyomaviruses and NHL risk. 
